Register free for our breaking news email alerts with analysis and cutting edge commentary from our award winning team. Registration only takes a minute.
Showing fund managers & funds available in United Kingdom. View fund & fund manager rankings globally

Funds & Fund Managers

All calculations in GBP, unless stated
over :
 Average Manager Total Return : 3.4% (30 April 2017 - 30 April 2018)
Total Return
1 of 125

12.7%

2 of 125

11.5%

3 of 125

10.0%

3 of 125

10.0%

5 of 125

9.7%

5 of 125

9.7%

5 of 125

9.7%

5 of 125

9.7%

9 of 125

9.5%

9 of 125

9.5%

11 of 125

9.1%

11 of 125

9.1%

13 of 125

8.6%

13 of 125

8.6%

15 of 125

8.4%

15 of 125

8.4%

15 of 125

8.4%

18 of 125

8.2%

19 of 125

8.0%

19 of 125

8.0%

21 of 125

7.8%

22 of 125

7.8%

22 of 125

7.8%

22 of 125

7.8%

25 of 125

7.4%

25 of 125

7.4%

27 of 125

7.2%

28 of 125

7.0%

29 of 125

6.9%

30 of 125

6.9%

31 of 125

6.7%

31 of 125

6.7%

33 of 125

6.7%

33 of 125

6.7%

35 of 125

6.5%

36 of 125

6.2%

37 of 125

6.2%

38 of 125

6.0%

39 of 125

5.9%

40 of 125

5.8%

41 of 125

5.6%

41 of 125

5.6%

43 of 125

5.5%

43 of 125

5.5%

45 of 125

5.1%

45 of 125

5.1%

47 of 125

5.1%

47 of 125

5.1%

49 of 125

5.0%

49 of 125

5.0%

51 of 125

4.9%

52 of 125

4.6%

52 of 125

4.6%

54 of 125

4.5%

55 of 125

4.1%

55 of 125

4.1%

57 of 125

4.0%

57 of 125

4.0%

59 of 125

3.9%

60 of 125

3.9%

60 of 125

3.9%

62 of 125

3.8%

62 of 125

3.8%

62 of 125

3.8%

62 of 125

3.8%

66 of 125

3.8%

66 of 125

3.8%

68 of 125

3.6%

69 of 125

3.5%

69 of 125

3.5%

71 of 125

3.4%

71 of 125

3.4%

73 of 125

3.4%

73 of 125

3.4%

75 of 125

3.1%

75 of 125

3.1%

77 of 125

3.0%

78 of 125

2.7%

79 of 125

2.6%

80 of 125

2.5%

81 of 125

2.4%

82 of 125

2.3%

83 of 125

2.2%

84 of 125

2.2%

85 of 125

1.8%

86 of 125

1.7%

87 of 125

1.6%

88 of 125

1.4%

88 of 125

1.4%

90 of 125

1.3%

90 of 125

1.3%

90 of 125

1.3%

93 of 125

1.2%

93 of 125

1.2%

95 of 125

0.7%

95 of 125

0.7%

97 of 125

0.6%

98 of 125

0.6%

98 of 125

0.6%

100 of 125

0.5%

101 of 125

0.3%

101 of 125

0.3%

101 of 125

0.3%

104 of 125

0.1%

105 of 125

0.1%

106 of 125

-0.4%

106 of 125

-0.4%

108 of 125

-0.9%

109 of 125

-1.5%

109 of 125

-1.5%

111 of 125

-1.6%

112 of 125

-1.7%

113 of 125

-2.3%

114 of 125

-2.6%

114 of 125

-2.6%

114 of 125

-2.6%

117 of 125

-2.9%

117 of 125

-2.9%

117 of 125

-2.9%

120 of 125

-3.2%

120 of 125

-3.2%

120 of 125

-3.2%

120 of 125

-3.2%

124 of 125

-9.4%

124 of 125

-9.4%

Managers with less than 12 months history are below. View 1 month performance
Show more managers
Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated). Portions of the information contained on this page was derived by Citywire Financial Publishers Ltd using content supplied by Lipper, A Reuters Company.

AJ Bell's 10 top selling funds in April

IFA clients of the AJ Bell platform haven't lost faith in the American dream, with a distinctly mid-Atlantic flavour to its top selling funds last month.

You're hired! The 20 top wealth and fund moves in April

As the sun began to come out in April, some big names jumped ship.

Shell falls as profits soar but cash flow disappoints

Fund managers welcome signs of continued progress at oil major, but shares slide at disappointment on cashflow dip.

Are bonds losing their place in multi-asset funds?

Bonds have long been a staple of multi-asset investing but the prospect of a bear market is leading investors to question this.

The hedge fund that's beaten Woodford twice

Small US hedge fund Kerrisdale Capital has been on the winning side of two high-profile clashes with Neil Woodford.

CityFibre soars as Jupiter, Invesco and Woodford accept bid

Fund groups agree to sell stakes in fibre broadband company to consortium of investors at 93% premium to yesterday's share price.

Woodford Patient Capital plunges as Prothena trial fails

Prothena, one of the big biotech bets of fund manager Neil Woodford, has failed a key drugs test, wiping two thirds from its market value and souring third anniversary of his Woodford Patient Capital Trust.

Capita jumps as Woodford and Barnett back cash call

Shares in embattled outsourcing group rally as investors welcome turnaround plan, with fund groups Woodford and Invesco backing rights issue.

OMGI scraps Asia team as global managers take on funds

Asian equity manager Josh Crabb and his team will leave in May following the changes, with Citywire AA-rated Ian Heslop set to take control of the funds.

AA delivers boost to Woodford as shares soar

Shares surge on bullish comments from boss, boosting fund manager Neil Woodford, the roadside recovery group's largest single shareholder.

Read More